Slideshow

Endo News Roundup: Fracture, Gestational Diabetes Risks

Author(s):

This month’s roundup covers hip fracture risk, improvements in diabetes-associated risk assessment, and a model to calculate gestational diabetes risk.

New studies on diabetes show current use of glucose-lowering drugs is associated with hip fracture in patients with type 2 mellitus (T2DM); standard methods of assessing bone health may underestimate the amount of risk fracture in diabetes patients; and a new tool can identify obese women who are at high risk of developing gestational DM early in pregnancy.

Related Videos
Diabetes Dialogue: Exploring New Horizons in Incretin Therapy for Diabetes and Weight Loss | Image Credit: HCPLive
Alice Cheng, MD: Exploring the Link Between Diabetes and Dementia | Image Credit: LinkedIn
Jennifer B. Green, MD: Implementation of Evidence-Based Therapies for T2D | Image Credit: Duke University
Ralph A. DeFronzo, MD: Noxious Nine and Mifepristone for Hypercortisolism in T2D | Image Credit: LinkedIn
Diabetes Dialogue: Diabetes Tech Updates from November 2024 | Image Credit: HCPLive
Viet Le, DMSc, PA-C | Credit: APAC
Diabetes Dialogue: Tirzepatide’s Long-Term Obesity Data | Image Credit: HCPLive
Diabetes Dialogue: Latest Updates on Semaglutide Shortage, Data | Image Credit: HCPLive
HCPLive CKD and CVD NewsNetwork Thumbnail
HCPLive CKD and CVD NewsNetwork Thumbnail
© 2024 MJH Life Sciences

All rights reserved.